_id
6913135bccc777a4e85d7f94
Ticker
MBRX
Name
Moleculin Biotech Inc
Exchange
NASDAQ
Address
5300 Memorial Drive, Houston, TX, United States, 77007
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://moleculin.com
Description
Moleculin Biotech, Inc., a late-stage pharmaceutical development company, engages in the development of therapeutic candidates for the treatment of tumors and viruses. Its lead drug candidate is Annamycin, an anthracycline, which is in clinical stage for the treatment of relapsed or refractory acute myeloid leukemia and soft tissue sarcoma lung metastases. The company is also developing WP1066 portfolio, including WP1066, WP1193, and WP1220, which are immune/transcription modulators designed to inhibit phosphorylated signal transducer and activator of transcription for brain tumors and pancreatic and other cancers. In addition, it is developing WP1122 portfolio, such as WP1122, WP1096, and WP1097 designed to exploit the uses of inhibitors of glycolysis comprising 2-deoxy-D-glucose for the treatment of pathogenic viruses and various cancers. The company was incorporated in 2015 and is headquartered in Houston, Texas.
Last Close
5
Volume
262662
Current Price
4.98
Change
-0.39999999999999153
Last Updated
2025-12-02T11:36:25.470Z
Image
data:image/webp;base64,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
Ipo Date
2016-06-02T00:00:00.000Z
Market Cap
22467404
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.8822000000000001
Sentiment Sources
5
Rating
3.6667
Target Price
6.6667
Strong Buy
0
Buy
2
Hold
1
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
21000
Gross Profit
-21000
Operating Expenses
5885000
Operating Income
-5906000
Interest Expense
-
Pretax Income
-25399000
Net Income
-25399000
Eps
-17.02142773851377
Dividends Per Share
-
Shares Outstanding
49498576
Income Tax Expense
-
EBITDA
-25378000
Operating Margin
-
Total Other Income Expense Net
-19493000
Cash
6703000
Short Term Investments
-
Receivables
6000
Inventories
-
Total Current Assets
7885000
Property Plant Equipment
420000
Total Assets
20353000
Payables
2116000
Short Term Debt
132000
Long Term Debt
-
Total Liabilities
47273000
Equity
-26920000
Depreciation
21000
Change In Working Capital
-1695000
Cash From Operations
-7223000
Capital Expenditures
0
Cash From Investing
-
Cash From Financing
6375000
Net Change In Cash
-854000
PE
-
PB
-0.2760418439821694
ROE
94.34992570579494
ROA
-124.79241389475753
FCF
-7223000
Fcf Percent
-
Piotroski FScore
1
Health Score
39
Deep Value Investing Score
1.5
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
5.8
Garp Investing Score
2
Growth Investing Score
2
Momentum Investing Score
2.5
Net Net Investing Score
1
Quality Investing Score
3
Value Investing Score
3
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
21000
Quarters > 0 > income Statement > gross Profit
-21000
Quarters > 0 > income Statement > operating Expenses
5885000
Quarters > 0 > income Statement > operating Income
-5906000
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-25399000
Quarters > 0 > income Statement > net Income
-25399000
Quarters > 0 > income Statement > eps
-17.02142773851377
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
1492178
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-25378000
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
-19493000
Quarters > 0 > balance Sheet > cash
6703000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
6000
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
7885000
Quarters > 0 > balance Sheet > property Plant Equipment
420000
Quarters > 0 > balance Sheet > total Assets
20353000
Quarters > 0 > balance Sheet > payables
2116000
Quarters > 0 > balance Sheet > short Term Debt
132000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
47273000
Quarters > 0 > balance Sheet > equity
-26920000
Quarters > 0 > cash Flow > net Income
-25399000
Quarters > 0 > cash Flow > depreciation
21000
Quarters > 0 > cash Flow > change In Working Capital
-1695000
Quarters > 0 > cash Flow > cash From Operations
-7223000
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
6375000
Quarters > 0 > cash Flow > net Change In Cash
-854000
Quarters > 0 > ratios > PE
-17.02142773851377
Quarters > 0 > ratios > PB
-0.2760418439821694
Quarters > 0 > ratios > ROE
94.34992570579494
Quarters > 0 > ratios > ROA
-124.79241389475753
Quarters > 0 > ratios > FCF
-7223000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
39
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
29000
Quarters > 1 > income Statement > gross Profit
-29000
Quarters > 1 > income Statement > operating Expenses
5691000
Quarters > 1 > income Statement > operating Income
-5720000
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-7640000
Quarters > 1 > income Statement > net Income
-7640000
Quarters > 1 > income Statement > eps
-12.301628194558944
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
621056
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-7611000
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
-1920000
Quarters > 1 > balance Sheet > cash
7557000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
5000
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
9076000
Quarters > 1 > balance Sheet > property Plant Equipment
469000
Quarters > 1 > balance Sheet > total Assets
21593000
Quarters > 1 > balance Sheet > payables
3721000
Quarters > 1 > balance Sheet > short Term Debt
128000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
28758000
Quarters > 1 > balance Sheet > equity
-7165000
Quarters > 1 > cash Flow > net Income
-7640000
Quarters > 1 > cash Flow > depreciation
28000
Quarters > 1 > cash Flow > change In Working Capital
-335000
Quarters > 1 > cash Flow > cash From Operations
-5582000
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
5423000
Quarters > 1 > cash Flow > net Change In Cash
-159000
Quarters > 1 > ratios > PE
-12.301628194558944
Quarters > 1 > ratios > PB
-0.4316620907187718
Quarters > 1 > ratios > ROE
106.62944870900208
Quarters > 1 > ratios > ROA
-35.38183670634002
Quarters > 1 > ratios > FCF
-5582000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
39
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
63000
Quarters > 2 > income Statement > cost Of Revenue
31000
Quarters > 2 > income Statement > gross Profit
-31000
Quarters > 2 > income Statement > operating Expenses
5943000
Quarters > 2 > income Statement > operating Income
-5943000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-6436000
Quarters > 2 > income Statement > net Income
-6436000
Quarters > 2 > income Statement > eps
-1722.2370885737223
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
3737
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-5912000
Quarters > 2 > income Statement > operating Margin
-9433.333333333332
Quarters > 2 > income Statement > total Other Income Expense Net
-493000
Quarters > 2 > balance Sheet > cash
7716000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
6000
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
9340000
Quarters > 2 > balance Sheet > property Plant Equipment
525000
Quarters > 2 > balance Sheet > total Assets
21013000
Quarters > 2 > balance Sheet > payables
2706000
Quarters > 2 > balance Sheet > short Term Debt
124000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
20971000
Quarters > 2 > balance Sheet > equity
42000
Quarters > 2 > cash Flow > net Income
-6436000
Quarters > 2 > cash Flow > depreciation
31000
Quarters > 2 > cash Flow > change In Working Capital
706000
Quarters > 2 > cash Flow > cash From Operations
-4564000
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
7999000
Quarters > 2 > cash Flow > net Change In Cash
3438000
Quarters > 2 > ratios > PE
-1722.2370885737223
Quarters > 2 > ratios > PB
0.4431014285714286
Quarters > 2 > ratios > ROE
-15323.809523809525
Quarters > 2 > ratios > ROA
-30.628658449531244
Quarters > 2 > ratios > FCF
-4564000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-72.44444444444444
Quarters > 2 > health Score
16
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
126000
Quarters > 3 > income Statement > cost Of Revenue
31000
Quarters > 3 > income Statement > gross Profit
-31000
Quarters > 3 > income Statement > operating Expenses
6612000
Quarters > 3 > income Statement > operating Income
-6643000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-1882000
Quarters > 3 > income Statement > net Income
-1882000
Quarters > 3 > income Statement > eps
-13.924650034034745
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
135156
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-1851000
Quarters > 3 > income Statement > operating Margin
-5272.222222222222
Quarters > 3 > income Statement > total Other Income Expense Net
4761000
Quarters > 3 > balance Sheet > cash
4278000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
20000
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
5194000
Quarters > 3 > balance Sheet > property Plant Equipment
583000
Quarters > 3 > balance Sheet > total Assets
16925000
Quarters > 3 > balance Sheet > payables
2030000
Quarters > 3 > balance Sheet > short Term Debt
120000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
10946000
Quarters > 3 > balance Sheet > equity
5979000
Quarters > 3 > cash Flow > net Income
-1882000
Quarters > 3 > cash Flow > depreciation
31000
Quarters > 3 > cash Flow > change In Working Capital
1046000
Quarters > 3 > cash Flow > cash From Operations
-5083000
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
1000
Quarters > 3 > cash Flow > net Change In Cash
-5127000
Quarters > 3 > ratios > PE
-13.924650034034745
Quarters > 3 > ratios > PB
0.11257348720521827
Quarters > 3 > ratios > ROE
-31.47683559123599
Quarters > 3 > ratios > ROA
-11.119645494830133
Quarters > 3 > ratios > FCF
-5083000
Quarters > 3 > ratios > Piotroski FScore
0
Quarters > 3 > ratios > fcf Percent
-40.34126984126984
Quarters > 3 > health Score
23
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
126000
Annuals > 0 > income Statement > gross Profit
-126000
Annuals > 0 > income Statement > operating Expenses
26641000
Annuals > 0 > income Statement > operating Income
-26641000
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-21763000
Annuals > 0 > income Statement > net Income
-21763000
Annuals > 0 > income Statement > eps
-158.023525994772
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
137720
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-26515000
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
4878000
Annuals > 0 > balance Sheet > cash
4278000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
20000
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
5194000
Annuals > 0 > balance Sheet > property Plant Equipment
583000
Annuals > 0 > balance Sheet > total Assets
16925000
Annuals > 0 > balance Sheet > payables
2030000
Annuals > 0 > balance Sheet > short Term Debt
120000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
10946000
Annuals > 0 > balance Sheet > equity
5979000
Annuals > 0 > cash Flow > net Income
-21763000
Annuals > 0 > cash Flow > depreciation
126000
Annuals > 0 > cash Flow > change In Working Capital
231000
Annuals > 0 > cash Flow > cash From Operations
-23862000
Annuals > 0 > cash Flow > capital Expenditures
13000
Annuals > 0 > cash Flow > cash From Investing
-13000
Annuals > 0 > cash Flow > cash From Financing
4635000
Annuals > 0 > cash Flow > net Change In Cash
-19272000
Annuals > 0 > ratios > PE
-158.023525994772
Annuals > 0 > ratios > PB
0.15271510286001003
Annuals > 0 > ratios > ROE
-363.99063388526514
Annuals > 0 > ratios > ROA
-128.58493353028064
Annuals > 0 > ratios > FCF
-23875000
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
24
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
127000
Annuals > 1 > income Statement > gross Profit
-127000
Annuals > 1 > income Statement > operating Expenses
29631000
Annuals > 1 > income Statement > operating Income
-29631000
Annuals > 1 > income Statement > interest Expense
-
Annuals > 1 > income Statement > pretax Income
-29769000
Annuals > 1 > income Statement > net Income
-29769000
Annuals > 1 > income Statement > eps
-376.70834176958897
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
79024
Annuals > 1 > income Statement > income Tax Expense
-
Annuals > 1 > income Statement > EBITDA
-29504000
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
-138000
Annuals > 1 > balance Sheet > cash
23550000
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
99000
Annuals > 1 > balance Sheet > inventories
1
Annuals > 1 > balance Sheet > total Current Assets
26273000
Annuals > 1 > balance Sheet > property Plant Equipment
796000
Annuals > 1 > balance Sheet > total Assets
38217000
Annuals > 1 > balance Sheet > payables
2498000
Annuals > 1 > balance Sheet > short Term Debt
100000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
12144000
Annuals > 1 > balance Sheet > equity
26073000
Annuals > 1 > cash Flow > net Income
-29769000
Annuals > 1 > cash Flow > depreciation
127000
Annuals > 1 > cash Flow > change In Working Capital
1622000
Annuals > 1 > cash Flow > cash From Operations
-24101000
Annuals > 1 > cash Flow > capital Expenditures
124000
Annuals > 1 > cash Flow > cash From Investing
-124000
Annuals > 1 > cash Flow > cash From Financing
4651000
Annuals > 1 > cash Flow > net Change In Cash
-19595000
Annuals > 1 > ratios > PE
-376.70834176958897
Annuals > 1 > ratios > PB
0.020094700264641583
Annuals > 1 > ratios > ROE
-114.17558393740651
Annuals > 1 > ratios > ROA
-77.89465421147656
Annuals > 1 > ratios > FCF
-24225000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
33
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
222000
Annuals > 2 > income Statement > gross Profit
-222000
Annuals > 2 > income Statement > operating Expenses
30640000
Annuals > 2 > income Statement > operating Income
-30640000
Annuals > 2 > income Statement > interest Expense
1615000
Annuals > 2 > income Statement > pretax Income
-29025000
Annuals > 2 > income Statement > net Income
-29025000
Annuals > 2 > income Statement > eps
-380.51600723668685
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
76278
Annuals > 2 > income Statement > income Tax Expense
-1615000
Annuals > 2 > income Statement > EBITDA
-30510000
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
1615000
Annuals > 2 > balance Sheet > cash
43145000
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
22000
Annuals > 2 > balance Sheet > inventories
-22000
Annuals > 2 > balance Sheet > total Current Assets
45596000
Annuals > 2 > balance Sheet > property Plant Equipment
678000
Annuals > 2 > balance Sheet > total Assets
57422000
Annuals > 2 > balance Sheet > payables
2095000
Annuals > 2 > balance Sheet > short Term Debt
116000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
5231000
Annuals > 2 > balance Sheet > equity
52191000
Annuals > 2 > cash Flow > net Income
-29025000
Annuals > 2 > cash Flow > depreciation
130000
Annuals > 2 > cash Flow > change In Working Capital
224000
Annuals > 2 > cash Flow > cash From Operations
-27639000
Annuals > 2 > cash Flow > capital Expenditures
67000
Annuals > 2 > cash Flow > cash From Investing
-67000
Annuals > 2 > cash Flow > cash From Financing
-23000
Annuals > 2 > cash Flow > net Change In Cash
-27758000
Annuals > 2 > ratios > PE
-380.51600723668685
Annuals > 2 > ratios > PB
0.009689853423003965
Annuals > 2 > ratios > ROE
-55.61303673047077
Annuals > 2 > ratios > ROA
-50.546828741597295
Annuals > 2 > ratios > FCF
-27706000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
33
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
260000
Annuals > 3 > income Statement > gross Profit
-260000
Annuals > 3 > income Statement > operating Expenses
22968000
Annuals > 3 > income Statement > operating Income
-22968000
Annuals > 3 > income Statement > interest Expense
7074000
Annuals > 3 > income Statement > pretax Income
-15894000
Annuals > 3 > income Statement > net Income
-15894000
Annuals > 3 > income Statement > eps
-221.7695237829466
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
71669
Annuals > 3 > income Statement > income Tax Expense
-7034000
Annuals > 3 > income Statement > EBITDA
-22804000
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
7074000
Annuals > 3 > balance Sheet > cash
70903000
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
45000
Annuals > 3 > balance Sheet > inventories
-45000
Annuals > 3 > balance Sheet > total Current Assets
72497000
Annuals > 3 > balance Sheet > property Plant Equipment
445000
Annuals > 3 > balance Sheet > total Assets
84090000
Annuals > 3 > balance Sheet > payables
1364000
Annuals > 3 > balance Sheet > short Term Debt
96000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
5097000
Annuals > 3 > balance Sheet > equity
78993000
Annuals > 3 > cash Flow > net Income
-15894000
Annuals > 3 > cash Flow > depreciation
164000
Annuals > 3 > cash Flow > change In Working Capital
1038000
Annuals > 3 > cash Flow > cash From Operations
-18951000
Annuals > 3 > cash Flow > capital Expenditures
19000
Annuals > 3 > cash Flow > cash From Investing
-19000
Annuals > 3 > cash Flow > cash From Financing
74724000
Annuals > 3 > cash Flow > net Change In Cash
55730000
Annuals > 3 > ratios > PE
-221.7695237829466
Annuals > 3 > ratios > PB
0.006015285784816376
Annuals > 3 > ratios > ROE
-20.12077019482739
Annuals > 3 > ratios > ROA
-18.901177310024973
Annuals > 3 > ratios > FCF
-18970000
Annuals > 3 > ratios > Piotroski FScore
1
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
34
Valuation > metrics > PE
-17.02142773851377
Valuation > metrics > PB
-0.2760418439821694
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > metrics > ROE
94.34992570579494
Profitability > metrics > ROA
-322.11794546607484
Profitability > final Score
55
Profitability > verdict
Weak
Risk > metrics > Interest Coverage
-281.23809523809524
Risk > final Score
-1095
Risk > verdict
High
Liquidity > metrics > Current Ratio
3.507562277580071
Liquidity > metrics > Quick Ratio
3.507562277580071
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
50
Prev Valuations > 1
70
Prev Valuations > 2
70
Prev Profitabilities > 0
55
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
-759
Prev Risks > 1
-39
Prev Risks > 2
-827
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-14T00:48:55.395Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-11-17
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.68
Earnings History > 0 > eps Estimate
-0.2633
Earnings History > 0 > eps Difference
-0.4167
Earnings History > 0 > surprise Percent
-158.2605
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-08-12
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
AfterMarket
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.49
Earnings History > 1 > eps Estimate
-0.4
Earnings History > 1 > eps Difference
-0.09
Earnings History > 1 > surprise Percent
-22.5
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-05-13
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
AfterMarket
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
-0.69
Earnings History > 2 > eps Estimate
-0.56
Earnings History > 2 > eps Difference
-0.13
Earnings History > 2 > surprise Percent
-23.2143
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-03-20
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
AfterMarket
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-0.557
Earnings History > 3 > eps Estimate
-1.2833
Earnings History > 3 > eps Difference
0.7263
Earnings History > 3 > surprise Percent
56.5963
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-11-08
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
AfterMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-2.85
Earnings History > 4 > eps Estimate
-2.44
Earnings History > 4 > eps Difference
-0.41
Earnings History > 4 > surprise Percent
-16.8033
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-08-13
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
AfterMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-1.7
Earnings History > 5 > eps Estimate
-2.51
Earnings History > 5 > eps Difference
0.81
Earnings History > 5 > surprise Percent
32.2709
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-05-10
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-2.02
Earnings History > 6 > eps Estimate
-3.53
Earnings History > 6 > eps Difference
1.51
Earnings History > 6 > surprise Percent
42.7762
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2024-03-22
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-5.02
Earnings History > 7 > eps Estimate
-3.05
Earnings History > 7 > eps Difference
-1.97
Earnings History > 7 > surprise Percent
-64.5902
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-11-13
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
BeforeMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.19
Earnings History > 8 > eps Estimate
-0.24
Earnings History > 8 > eps Difference
0.05
Earnings History > 8 > surprise Percent
20.8333
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-08-10
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
AfterMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.2
Earnings History > 9 > eps Estimate
-0.27
Earnings History > 9 > eps Difference
0.07
Earnings History > 9 > surprise Percent
25.9259
Earnings History > 10 > period
2023-03-31
Earnings History > 10 > report Date
2023-05-10
Earnings History > 10 > date
2023-03-31
Earnings History > 10 > before After Market
AfterMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.28
Earnings History > 10 > eps Estimate
-0.25
Earnings History > 10 > eps Difference
-0.03
Earnings History > 10 > surprise Percent
-12
Earnings History > 11 > period
2022-12-31
Earnings History > 11 > report Date
2023-03-22
Earnings History > 11 > date
2022-12-31
Earnings History > 11 > before After Market
AfterMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.23
Earnings History > 11 > eps Estimate
-0.3
Earnings History > 11 > eps Difference
0.07
Earnings History > 11 > surprise Percent
23.3333
Earnings History > 12 > period
2022-09-30
Earnings History > 12 > report Date
2022-11-10
Earnings History > 12 > date
2022-09-30
Earnings History > 12 > before After Market
AfterMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.3
Earnings History > 12 > eps Estimate
-0.27
Earnings History > 12 > eps Difference
-0.03
Earnings History > 12 > surprise Percent
-11.1111
Earnings History > 13 > period
2022-06-30
Earnings History > 13 > report Date
2022-08-15
Earnings History > 13 > date
2022-06-30
Earnings History > 13 > before After Market
BeforeMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.24
Earnings History > 13 > eps Estimate
-0.25
Earnings History > 13 > eps Difference
0.01
Earnings History > 13 > surprise Percent
4
Earnings History > 14 > period
2022-03-31
Earnings History > 14 > report Date
2022-05-11
Earnings History > 14 > date
2022-03-31
Earnings History > 14 > before After Market
AfterMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.24
Earnings History > 14 > eps Estimate
-0.21
Earnings History > 14 > eps Difference
-0.03
Earnings History > 14 > surprise Percent
-14.2857
Earnings History > 15 > period
2021-12-31
Earnings History > 15 > report Date
2022-03-24
Earnings History > 15 > date
2021-12-31
Earnings History > 15 > before After Market
AfterMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.09
Earnings History > 15 > eps Estimate
-0.21
Earnings History > 15 > eps Difference
0.12
Earnings History > 15 > surprise Percent
57.1429
Earnings History > 16 > period
2021-09-30
Earnings History > 16 > report Date
2021-11-10
Earnings History > 16 > date
2021-09-30
Earnings History > 16 > before After Market
AfterMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.15
Earnings History > 16 > eps Estimate
-0.2
Earnings History > 16 > eps Difference
0.05
Earnings History > 16 > surprise Percent
25
Earnings History > 17 > period
2021-06-30
Earnings History > 17 > report Date
2021-08-11
Earnings History > 17 > date
2021-06-30
Earnings History > 17 > before After Market
AfterMarket
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.15
Earnings History > 17 > eps Estimate
-0.19
Earnings History > 17 > eps Difference
0.04
Earnings History > 17 > surprise Percent
21.0526
Earnings History > 18 > period
2021-03-31
Earnings History > 18 > report Date
2021-05-12
Earnings History > 18 > date
2021-03-31
Earnings History > 18 > before After Market
BeforeMarket
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-0.2
Earnings History > 18 > eps Estimate
-0.23
Earnings History > 18 > eps Difference
0.03
Earnings History > 18 > surprise Percent
13.0435
Earnings History > 19 > period
2020-12-31
Earnings History > 19 > report Date
2021-03-24
Earnings History > 19 > date
2020-12-31
Earnings History > 19 > before After Market
BeforeMarket
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-0.26
Earnings History > 19 > eps Estimate
-0.58
Earnings History > 19 > eps Difference
0.32
Earnings History > 19 > surprise Percent
55.1724
Earnings History > 20 > period
2020-09-30
Earnings History > 20 > report Date
2020-11-12
Earnings History > 20 > date
2020-09-30
Earnings History > 20 > before After Market
AfterMarket
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-0.36
Earnings History > 20 > eps Estimate
-0.56
Earnings History > 20 > eps Difference
0.2
Earnings History > 20 > surprise Percent
35.7143
Earnings History > 21 > period
2020-06-30
Earnings History > 21 > report Date
2020-08-12
Earnings History > 21 > date
2020-06-30
Earnings History > 21 > before After Market
BeforeMarket
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-1.02
Earnings History > 21 > eps Estimate
-0.54
Earnings History > 21 > eps Difference
-0.48
Earnings History > 21 > surprise Percent
-88.8889
Earnings History > 22 > period
2020-03-31
Earnings History > 22 > report Date
2020-05-11
Earnings History > 22 > date
2020-03-31
Earnings History > 22 > before After Market
AfterMarket
Earnings History > 22 > currency
USD
Earnings History > 22 > eps Actual
-0.12
Earnings History > 22 > eps Estimate
-0.6
Earnings History > 22 > eps Difference
0.48
Earnings History > 22 > surprise Percent
80
Earnings History > 23 > period
2019-12-31
Earnings History > 23 > report Date
2020-03-19
Earnings History > 23 > date
2019-12-31
Earnings History > 23 > before After Market
AfterMarket
Earnings History > 23 > currency
USD
Earnings History > 23 > eps Actual
-0.48
Earnings History > 23 > eps Estimate
-0.66
Earnings History > 23 > eps Difference
0.18
Earnings History > 23 > surprise Percent
27.2727
Earnings History > 24 > period
2019-09-30
Earnings History > 24 > report Date
2019-11-12
Earnings History > 24 > date
2019-09-30
Earnings History > 24 > before After Market
BeforeMarket
Earnings History > 24 > currency
USD
Earnings History > 24 > eps Actual
-0.54
Earnings History > 24 > eps Estimate
-0.51
Earnings History > 24 > eps Difference
-0.03
Earnings History > 24 > surprise Percent
-5.8824
Earnings History > 25 > period
2019-06-30
Earnings History > 25 > report Date
2019-08-16
Earnings History > 25 > date
2019-06-30
Earnings History > 25 > before After Market
AfterMarket
Earnings History > 25 > currency
USD
Earnings History > 25 > eps Actual
-0.18
Earnings History > 25 > eps Estimate
-0.63
Earnings History > 25 > eps Difference
0.45
Earnings History > 25 > surprise Percent
71.4286
Earnings History > 26 > period
2019-03-31
Earnings History > 26 > report Date
2019-05-13
Earnings History > 26 > date
2019-03-31
Earnings History > 26 > before After Market
AfterMarket
Earnings History > 26 > currency
USD
Earnings History > 26 > eps Actual
-0.84
Earnings History > 26 > eps Estimate
-0.54
Earnings History > 26 > eps Difference
-0.3
Earnings History > 26 > surprise Percent
-55.5556
Earnings History > 27 > period
2018-12-31
Earnings History > 27 > report Date
2019-02-21
Earnings History > 27 > date
2018-12-31
Earnings History > 27 > before After Market
AfterMarket
Earnings History > 27 > currency
USD
Earnings History > 27 > eps Actual
-0.6
Earnings History > 27 > eps Estimate
-0.6
Earnings History > 27 > eps Difference
0
Earnings History > 27 > surprise Percent
0
Earnings History > 28 > period
2018-09-30
Earnings History > 28 > report Date
2018-11-13
Earnings History > 28 > date
2018-09-30
Earnings History > 28 > before After Market
BeforeMarket
Earnings History > 28 > currency
USD
Earnings History > 28 > eps Actual
-0.48
Earnings History > 28 > eps Estimate
-0.78
Earnings History > 28 > eps Difference
0.3
Earnings History > 28 > surprise Percent
38.4615
Earnings History > 29 > period
2018-06-30
Earnings History > 29 > report Date
2018-08-13
Earnings History > 29 > date
2018-06-30
Earnings History > 29 > before After Market
BeforeMarket
Earnings History > 29 > currency
USD
Earnings History > 29 > eps Actual
-1.2
Earnings History > 29 > eps Estimate
-0.84
Earnings History > 29 > eps Difference
-0.36
Earnings History > 29 > surprise Percent
-42.8571
Earnings History > 30 > period
2018-03-31
Earnings History > 30 > report Date
2018-05-15
Earnings History > 30 > date
2018-03-31
Earnings History > 30 > before After Market
BeforeMarket
Earnings History > 30 > currency
USD
Earnings History > 30 > eps Actual
-0.48
Earnings History > 30 > eps Estimate
-0.84
Earnings History > 30 > eps Difference
0.36
Earnings History > 30 > surprise Percent
42.8571
Earnings History > 31 > period
2017-12-31
Earnings History > 31 > report Date
2018-03-28
Earnings History > 31 > date
2017-12-31
Earnings History > 31 > before After Market
BeforeMarket
Earnings History > 31 > currency
USD
Earnings History > 31 > eps Actual
-0.96
Earnings History > 31 > eps Estimate
-0.72
Earnings History > 31 > eps Difference
-0.24
Earnings History > 31 > surprise Percent
-33.3333
Earnings History > 32 > period
2017-09-30
Earnings History > 32 > report Date
2017-11-14
Earnings History > 32 > date
2017-09-30
Earnings History > 32 > before After Market
BeforeMarket
Earnings History > 32 > currency
USD
Earnings History > 32 > eps Actual
-0.14
Earnings History > 32 > eps Estimate
-
Earnings History > 32 > eps Difference
0
Earnings History > 32 > surprise Percent
-
Earnings History > 33 > period
2017-06-30
Earnings History > 33 > report Date
2017-08-14
Earnings History > 33 > date
2017-06-30
Earnings History > 33 > before After Market
BeforeMarket
Earnings History > 33 > currency
USD
Earnings History > 33 > eps Actual
-0.19
Earnings History > 33 > eps Estimate
-
Earnings History > 33 > eps Difference
0
Earnings History > 33 > surprise Percent
-
Earnings History > 34 > period
2017-03-31
Earnings History > 34 > report Date
2017-05-12
Earnings History > 34 > date
2017-03-31
Earnings History > 34 > before After Market
AfterMarket
Earnings History > 34 > currency
USD
Earnings History > 34 > eps Actual
-0.72
Earnings History > 34 > eps Estimate
-0.66
Earnings History > 34 > eps Difference
-0.06
Earnings History > 34 > surprise Percent
-9.0909
Earnings History > 35 > period
2016-09-30
Earnings History > 35 > report Date
2016-11-21
Earnings History > 35 > date
2016-09-30
Earnings History > 35 > before After Market
AfterMarket
Earnings History > 35 > currency
USD
Earnings History > 35 > eps Actual
-0.12
Earnings History > 35 > eps Estimate
-0.11
Earnings History > 35 > eps Difference
-0.01
Earnings History > 35 > surprise Percent
-9.0909
Earnings History > 36 > period
2016-06-30
Earnings History > 36 > report Date
2016-08-15
Earnings History > 36 > date
2016-06-30
Earnings History > 36 > before After Market
AfterMarket
Earnings History > 36 > currency
USD
Earnings History > 36 > eps Actual
-0.0832
Earnings History > 36 > eps Estimate
-
Earnings History > 36 > eps Difference
0
Earnings History > 36 > surprise Percent
-
Moleculin Biotech, Inc., a late-stage pharmaceutical development company, engages in the development of therapeutic candidates for the treatment of tumors and viruses. Its lead drug candidate is Annamycin, an anthracycline, which is in clinical stage for the treatment of relapsed or refractory acute myeloid leukemia and soft tissue sarcoma lung metastases. The company is also developing WP1066 portfolio, including WP1066, WP1193, and WP1220, which are immune/transcription modulators designed to inhibit phosphorylated signal transducer and activator of transcription for brain tumors and pancreatic and other cancers. In addition, it is developing WP1122 portfolio, such as WP1122, WP1096, and WP1097 designed to exploit the uses of inhibitors of glycolysis comprising 2-deoxy-D-glucose for the treatment of pathogenic viruses and various cancers. The company was incorporated in 2015 and is headquartered in Houston, Texas.
Stock Price
$ 0.00
0% decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AShowing 2 of 10
(Last Updated 2025-09-30)
Rating:
BUY
Target Price:
$6.6667
Analyst Picks
Strong Buy
0
Buy
2
Hold
1
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very High
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
* Institutions hold a combined 2.07% of the total shares of Moleculin Biotech Inc
1.
Vanguard Institutional Extnd Mkt Idx Tr(0.2889%)
since
2025/07/31
2.
Citigroup Inc(0.2816%)
since
2025/06/30
3.
XTX Topco Ltd(0.2451%)
since
2025/06/30
4.
Fidelity Extended Market Index(0.2198%)
since
2025/07/31
5.
Virtu Financial LLC(0.1957%)
since
2025/06/30
6.
LPL Financial Corp(0.1852%)
since
2025/06/30
7.
VERUS CAPITAL PARTNERS, LLC(0.142%)
since
2025/06/30
8.
Vanguard Group Inc(0.1021%)
since
2025/06/30
9.
Geode Capital Management, LLC(0.0909%)
since
2025/06/30
10.
Fidelity Series Total Market Index(0.0674%)
since
2025/07/31
11.
CAMBRIDGE Invest RESEARCH ADVISORS, INC.(0.0422%)
since
2025/06/30
12.
BlackRock Inc(0.0409%)
since
2025/06/30
13.
BB&T Corp.(0.0347%)
since
2025/06/30
14.
Spartan Total Market Index Pool G(0.028%)
since
2025/07/31
15.
UBS Group AG(0.0264%)
since
2025/06/30
16.
Tower Research Capital LLC(0.0129%)
since
2025/06/30
17.
Stone House Investment Management, LLC(0.0109%)
since
2025/06/30
18.
Newbridge Financial Services Group, Inc.(0.0095%)
since
2025/06/30
19.
Fidelity Total Market Index(0.0068%)
since
2025/07/31
20.
NT Ext Equity Mkt Idx Fd - NL(0.0058%)
since
2025/06/30
21.
Northern Trust Extended Eq Market Idx(0.0057%)
since
2025/06/30
22.
NT Ext Equity Mkt Idx Fd - L(0.0057%)
since
2025/06/30
23.
NT Ext Equity Mkt Idx Fd - DC - NL - T2(0.0045%)
since
2025/06/30
24.
Morgan Stanley - Brokerage Accounts(0.0031%)
since
2025/06/30
25.
State St US Extended Mkt Indx NL Cl C(0.0026%)
since
2025/08/31
26.
SBI Securities Co Ltd(0.0025%)
since
2025/06/30
27.
Vanguard U.S. Eq Idx £ Acc(0.0021%)
since
2025/07/31
28.
NT Ext Eq Mkt Indx Fd DC Lending Tier 5(0.0016%)
since
2025/06/30
29.
Spartan Extended Market Index Pool F(0.0015%)
since
2025/07/31
30.
NT Ext Eq Mkt Indx Fd DC Lend T3(0.0014%)
since
2024/12/31
31.
Atlantic Union Bankshares Corp(0.0013%)
since
2025/06/30
32.
Barclays PLC(0.0011%)
since
2025/03/31
33.
SSgA U.S. Total Market Index Strategy(0.0011%)
since
2025/03/31
34.
Bogart Wealth, LLC(0.001%)
since
2025/06/30
35.
State St US Ttl Mkt Indx NL Cl A(0.0007%)
since
2025/08/31
36.
Bank of America Corp(0.0005%)
since
2025/06/30
37.
Northern Trust Wilshire 5000(0.0003%)
since
2025/06/30
38.
Fidelity U.S. Equity Index Ins Trust(0%)
since
2025/07/31
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-0.68
EPS Estimate
-0.2633
EPS Difference
-0.4167
Surprise Percent
-158.2605%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.